key: cord-0857673-le7kjvwh
authors: Sedighi, Iraj; Fahimzad, Alireza; Pak, Neda; Khalili, Mitra; Shokrollahi, Mohammad R.; Heydari, Hosein; Movahedi, Zahra; Dashti, Anahita S.; Cheraghali, Fatemeh; Shamsizadeh, Ahmad; Mirkarimi, Mohammadreza; Alisamir, Mohsen; Hashemian, Houman; Soltani, Jafar; Hosseininasab, Ali; Hamedi, Abdolkarim; Rezai, Mohammad S.; Sayyahfar, Shirin; Kahbazi, Manijeh; Abedini, Aliakbar; Akhondzadeh, Afsaneh; Sherkatolabbasieh, Hamid R.; Razlansari, Ali Akbar; Alibeik, Mina; Malayeri, Soheil Omid; Shalchi, Zohreh; Shahabinezhad, Ali; Asl, Parinaz K.; Monfared, Fatemeh N.; Maleki, Shiva; Kakavand, Rezvan; Farahmand, Mohammad; Shahbaz, Babak; Tavakoli, Ahmad; Rezayat, Sara A.; Karimi, Mohammad R.; Erfani, Yousef; Jafarpour, Ali; Soltani, Saber; Zandi, Milad; Ghaziasadi, Azam; Dowran, Razieh; Azimi, Shohreh; Marvi, Shima S.; Abazari, Mohammad F.; Norouzi, Mehdi; Azhar, Iman R.; Jazayeri, Seyed M.
title: A multicenter retrospective study of clinical features, laboratory characteristics, and outcomes of 166 hospitalized children with coronavirus disease 2019 (COVID‐19): A preliminary report from Iranian Network for Research in Viral Diseases (INRVD)
date: 2021-11-30
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.25756
sha: f59241c703fd49ab73924b302484446b7187e4ee
doc_id: 857673
cord_uid: le7kjvwh

BACKGROUND: The objectives of this study were to analyze the clinical features and laboratory profiles and risk factors associated with critical illness of children with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). METHODS: One hundred and sixty‐six coronavirus disease 2019 (COVID‐19) Iranian pediatric patients were recruited through a collaborative research network between March and May 2020. Demographics, clinical, laboratory, and radiological results were obtained from patient files. RESULTS: Of 166 patients, 102 (61%) and 64 (39%) were males and females, respectively. Ninety‐six (57.8%) and 70 (42.2%), had moderate and severe conditions, respectively. Thirty (18%) of patients died. The common symptoms were fever (73%), cough (54%), and shortness of breath, headache decrease in neutrophil and platelet counts; increase values in lactate dehydrogenase, decrease in the blood pH and HCO(3) were significantly associated with the disease severity. 54% and 56% of patients showed abnormal radiographic appearance in Chest X‐ray and in chest computed tomography scan, respectively. Sixty‐one (36.7%) of patients were referred to intensive care unit (ICU). The coexistence of comorbidity was the main factor associated with ICU admission, shock, arrhythmia, acute kidney injury, acute respiratory distress syndrome, acute cardiac injury, and death. CONCLUSIONS: We describe a higher than previously recognized rate of COVID‐19 mortality in Iranian pediatric patients. Epidemiological factors, such as the relatively high case fatality rate in the country and the presence of underlying diseases were the main factors for the high death rate.

K E Y W O R D S children, COVID-19, severe acute respiratory syndrome coronavirus-2 1 | BACKGROUND For reasons that are yet to be clarified, the course of coronavirus disease 2019 , caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in children seems to be generally mild compared with that seen in adults. 1, 2 Worldwide published reports have confirmed the small proportion of confirmed COVID-19 cases and lower mortality rate in children. [3] [4] [5] [6] Several hypotheses have been proposed so far for the mildness nature of COVID-19 disease in pediatrics, including: highly effectiveness of innate immune response in this age groups, 7 early childhood measles, mumps, and rubella (MMR) vaccination (due to molecular mimicry between amino acid residues), 8 memory to a cross-reactive antigen because of cross-reaction to related coronavirus strains from earlier infection (antibody-dependent enhancement due to original antigenic sin) 9 and protection of children against COVID-19 as a result of cross-immunity due to previous exposure to seasonal coronavirus. 10 Apart from the immunological point of view, the lower prevalence of cardiovascular diseases, diabetes types 2, and fair body max index (BMI) in children compared with adults might be the underlying reasons for such less disease prevalence and aggressiveness.

On the other hand, due to the aggressive nature of COVID-19, severe and fatal cases in children are expected to be continued and also to be increased due to its global spread along with the growing community transmission and overall current disease prevalence. Indeed, the proportions of severe and critical cases stratified by several age sub-categories obtained from a recent report from China on 2143 children with suspected COVID-19 were 10.6% for < 1 year, 7.3% for 1-5 years, 4.2% for 6-10 years, 4.1% for 11-15 years, and 3.0% for ≥16 years. 11 In the USA, children less than 18 years account for nearly 10%-13% of laboratory-confirmed cases reported to the Centers for Disease Control and Prevention (CDC). 12, 13 Other international data released so far indicated the same pattern. Of 137,047,945 population aged between 0 and 19 years old from seven countries, COVID-19 deaths as percentage of all-cause deaths reported to be only 0.48%. 14 Other investigation carried out on 585 pediatrics cases from 25 European countries showed 0.68% mortality rate. 15 Since the COVID-19 pandemic, Iran has been among the list of the most affected countries in the world 16, 17 and the estimated COVID-19 case fatality rate in Iran ranged from 1.85% 18 to 10.5%. 19 Nevertheless, information regarding COVID-19 among Iranian pediatrics is scarce. Those studies were single-center based and they were suffered from small sample sizes. All samples were referred to regional referral laboratories across the country using recommended real-time reverse transcriptasepolymerase chain reaction (RT-PCR) assays. 20 All enrolled patients in this investigation were diagnosed for COVID-19 according to the criteria formulated by the Iranian CDC. Subsequently, the severity of COVID-19 between subjects was classified into an asymptomatic infection, as mild, moderate, severe, or critical in line with clinical features, laboratory testing, and chest scan imaging. All the laboratory-confirmed cases (166) were included in the analysis. For assessing the severity of disease, the following criteria were considered. 

Laboratory examinations included routine testing and measurement of biomarkers for monitoring lung, liver, and renal functions together with hematologic parameters, were carried out within general hospitals laboratories using CE-IVD assays.

Screening for SARS-Cov-2 was performed for all pediatric cases admitted to the hospitals for the suspension of COVID-19 infection.

According to Iranian CDC guidelines, SARS-Cov-2 infection was confirmed by real-time reverse transcription-polymerase chain reaction (RT-PCR) testing on throat specimens using flocked swabs, which were collected immediately upon admission. Collaborative clinical virology was obliged to apply two sets of primers for two target genes (E and RdP genes). The Iranian Pasture Institute provided these dual-target detection kits along with a protocol for all laboratories across the country. If respiratory samples obtained from patients were successfully tested positive by either or both genes, the specimens would have been considered positive, and the case was considered laboratory-confirmed.

According to the guidelines issued by The Ministry of Health, all COVID-19 confirmed cases with any respiratory symptoms undergo a chest X-ray upon admission. A chest CT scan usually applies in the case of either the presence of any abnormality in their X-ray or for the patients who progress to the severe form of the disease.

Demographic data, exposure and medical history, clinical signs and symptoms at presentation, laboratory examinations, imaging data, and outcomes on all pediatric patients admitted to the hospital during the study period were placed in a predefined, standardized, fieldtested electronic form provided by INRVD.

All statistical analyses were performed using Statistical Package for the Social Sciences (SPSS) for Windows release 25.0 (SPSS Inc.).

Descriptive statistics were generated for demographic and clinical characteristics. χ² or Fisher's exact tests were also used to compare categorical variables. To explore the risk factors associated with disease severity, multivariable logistic regression models were used.

Regarding the total number of severe cases in this study (n = 166) and

to avoid overfitting in the model, five variables were chosen for multivariate analysis based on previous findings and clinical constraints. p-values less than 0.05 were considered to indicate significance statistically.

Of the total number of 166 pediatrics patients, 102 (61%) and 64 (39%) were males and females, respectively. The age of subjects ranged between 0 and 15 years old. The median age of the patients was 5.08 (interquartile range [IQR]: 1.5-12). There was no significant correlation between the distributions of cases in different age groups (p-value = 0.2). Logistic regression however showed a significant association between age groups with the severity of the disease ( Table 1) 

All 166 patients had at least one symptom before the admission. One hundred and twenty-two (73%) had a fever. The common respiratory symptoms were cough (54%), shortness of breath (36%), sore throat Other signs including, wheezing, coarse respiratory crackles, and cyanosis, did not substantially correlate with disease severity.

In the process of interpretation and analyzing the data, there was a high percentage of heterogeneity in the hematological and biochemistry results. Taken into consideration, to avoid any false data outputs, only those data which met the criteria have been included in the results. Therefore, the presented results have not included the whole study population.

Based on the results of the logistic regression, there was a significant association between the severity of the disease with decreased in neutrophil and platelet counts (OR = 0.01, 95% CI: 0.00-0.09; p = 0.001 and 12.2, 95% CI: 1.81-123; p = 0.018, respectively, Table 1 ). Among a list of biochemistry results, only increased levels of LDH was statistically associated with the severity of the disease (OR = 5.27, 95% CI: 1.28-28.4; p = 0.034).

At the beginning of the pandemic and due to the shortage of facilities in some hospitals, blood saturation tests were carried only for 82 patients. A decrease in the blood pH and HCO 3 was associated with the illness severity (p values 0.002 and <0.001, respectively).

Conversely, PO 2 and PCO 2 levels had no significant correlation with the disease outcome (results not shown).

Overall, of 137 patients who undertook chest X-ray, 54% showed abnormal radiographic appearance, whereas, in the chest CT scan from 111 subjects, 56% showed abnormal features. Statistics showed that chest X-ray abnormal results had a significant correlation with disease severity (p values < 0.001). Ground glass opacity (36.6%), lung consolidation (25.2%), peripheral airspace opacities (22.6%), patchy infiltration (15.5%), and pleural effusion (9.8%), were the common radiological findings (results not shown). Table 2 and Figure 1 show the correlation between different age groups and disease severity. Ninety-six (57.8%) and 70 (42.2%), had moderate and severe conditions, respectively. No significant correlation was found between different age groups of patients and death (p-value 0.12, Table 2 ). In total, 69 (41.5%) of patients had a history of at least one underlying disease. Malignancies (20, 12%), and heart disease (9, 5.4%) were amongst the most common comorbidities among the cases. Other morbidities were included: asthma (4, 2.4%), cystic fibrosis (1, 0.6%), chronic kidney diseases (4, 2.4%), diabetes (1, 0.6%), failure to thrive (4,

Thirty (18%) of patients died. Among a list of biochemistry results, only increased levels of LDH were statistically associated with the severity of the disease (Table 1) .

A long list of abnormal laboratory parameters has been reported in several publications from different countries with a variety of heterogeneity between studies. However, no absolute biochemistry indexes have been found to be associated with disease severity so far.

Blood saturation tests were accomplished only for 82 patients.

A decrease in the blood pH and HCO 3 was associated with the disease severity. However, PO 2 and PCO 2 levels had no significant correlation with the disease outcome. Not many data are available in the database to compare blood saturation values and the disease severity between COVID-19 positive children.

In the chest X-ray, 54% and in chest CT scan, 56% of patients showed normal radiographic appearance. Normal radiological results among pediatrics COVID-19 patients results were found in 20%, 29 27%, 1 37.9%, 25 and 42.9%-45% 24 of patients with confirmed COVID-19 disease. The present study showed that ground-glass opacity and lung consolidation showed significant correlations with disease severity. Similar findings were observed by others. 1, 22, 24, 29 Two studies compared the radiological features between severe versus non-severe cases. 22, 23 Both surveys found unilateral or bilateral opacities in CT scans of patients among two groups of patients. However, patchy consolidation was less frequently detected for nonsevere children. 23 We did not find a significant correlation between different age groups and clinical outcomes, with the exception of ARDS and AKI (pvalues 0.032 and 0.024, respectively). Even more, death was not related to a specific age group (p-values 0.12). Only admission to ICU was correlated to age group (p value, 0.048).

Death rates are relatively few cases among children. A systematic review across seven studies for which the information about mortality outcomes was available, there were a total of only five pediatric mor- On the other hand, many others recent reports emphasized the negative influence of the previous history of congenital or acquired diseases on the outcome of COVID 19 among children. 23, 29, [38] [39] [40] It is tempting to speculate that unlike the adults, underlying diseases are rare in children (such as diabetes mellitus, cardiovascular disease, or chronic kidney diseases).

These underlying diseases may persuade patients to severe medical conditions during COVID-19. Nevertheless, the causes of death yet to be determined globally.

In conclusion, the present study clearly showed that Iranian pediatric 

Mofid Children Hospital, Tehran; Nemazee Hospital, Shiraz; Imam Khomeini Hospital, Tehran; Aboozar Children' Hospital, Ahvaz; Be'sat Hospital, Hamadan; Taleqani Hospital

Shahrivar Children's Hospital, Rasht; Ibn-Sina Hospital Sari

Ali Asghar Children's Hospital, Tehran; Children's Hospital, Tabriz; Shahid Rahimi Hospital of

This study was financially supported by Iranian Ministry of Health

Hosein Heydari: data curation (equal). Zahra Movahedi: data curation (equal)

Ali Akbar Razlansari: data curation (equal). Mina Alibeik: data curation (equal)

Ahmad Tavakoli: writing review & editing (equal)

Shima Sadeghipour Marvi: data curation (equal)

Seyed Mohammad Jazayeri: funding acquisition (lead); supervision (lead)

Clinical characteristics and diagnostic challenges of pediatric COVID-19: a systematic review and meta-analysis

Laboratory abnormalities in children with novel coronavirus disease 2019

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

Children were less frequently infected with SARS-CoV-2 than adults during

COVID-19 pandemic in Warsaw, Poland

Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults

COVID-19 in children: analysis of the first pandemic peak in England

Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic

Does early childhood vaccination protect against COVID-19?

Antibody dependent enhancement due to original antigenic sin and the development of SARS

COVID-19 is milder in children possibly due to cross immunity

Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China

Demographic trends of COVID-19 cases and deaths in the US reported to the CDC

State-Level Data Report

Children and young people remain at low risk of COVID-19 mortality. The Lancet Child & Adolescent Health

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child & Adolescent Health

Quantitative assessment of the role of undocumented infection in the 2019 novel coronavirus (COVID-19) pandemic

Decreased case fatality rate of COVID-19 in the second wave: a study in 53 countries or regions

Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study

Baseline characteristics and associated factors of mortality in COVID-19 patients; an analysis of 16000 cases in Tehran

World Health Organization (WHO)Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance

Epidemiology of COVID-19 among children in China

Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 (COVID-19) at a Tertiary Care Medical Center

Children hospitalized with severe COVID-19 in Wuhan

Pediatric COVID-19: systematic review of the literature

Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan

SARS-CoV-2 infections among children in the biospecimens from respiratory virus-exposed kids (BRAVE kids) study. medRxiv

CDC COVID-19 Response Team. Coronavirus disease 2019 in children-United States

Clinical analysis of 25 COVID-19 infections in children

Clinical and CT features in pediatric patients with COVID-19 infection: different points from adults

Performance of radiologists in differentiating COVID-19 from non-COVID-19 viral pneumonia on chest CT

Clinical characteristics of COVID-19 in China

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Defining the epidemiology of COVID-19-studies needed

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China

Epidemiology, characteristics, and outcomes of hospitalized children with COVID-19 in Oman: A multicenter cohort study

Characteristics and outcomes of coronavirus disease 2019 (COVID-19) in criticallyill pediatric patients admitted to the intensive care unit: a multicenter retrospective cohort study

Demographic predictors of hospitalization and mortality in US children with COVID-19

A multicenter retrospective study of clinical features, laboratory characteristics, and outcomes of 166 hospitalized children with coronavirus disease 2019 (COVID-19): A preliminary report from Iranian Network for Research in Viral Diseases (INRVD)

The data that support the findings of this study are available from the corresponding author upon reasonable request.